https://doi.org/10.1038/srep26157
U
Upkar S. Gill
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
158
Papers
6.0K
Citations
31
h-index
47
i10-index
Upkar S. Gill is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Hepatitis B Virus Studies & Hepatitis C virus research & Liver Disease Diagnosis and Treatment. The author has an h-index of 31, co-authored 135 publications.
ORCID: 0000-0001-6146-9708Papers by this author
worksCXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
2016 · Scientific Reports · 231 citations
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients
2022 · Med · 56 citations
https://doi.org/10.1016/j.medj.2021.12.004
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
2017 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-017-05845-5
HBV Biomarkers and Their Role in Guiding Treatment Decisions
2024 · Seminars in Liver Disease · 3 citations
https://doi.org/10.1055/a-2448-4157
Chronic hepatitis B in 2025: diagnosis, treatment and future directions
2025 · Clinical Medicine · 2 citations
https://doi.org/10.1016/j.clinme.2025.100527
The genetic landscape of hepatitis delta virus infection
2020 · Clinical Medicine · 0 citations
https://doi.org/10.7861/clinmed.20-2-s101
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat